SCHEMBL6147435

SCHEMBL6147435

C=CCNC(=O)NC(=O)CC=C

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
TSHR P16473 2/20 0.48
MAPT P10636 1/20 0.48
KMT2A Q03164 2/20 0.41
FAAH O00519 1/20 0.40
ALDH1A1 P00352 4/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 2/20 0.36
HTT P42858 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138597 0.84 SMN1; SMN2 (0.52) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL31386 0.81
SCHEMBL17859667 0.81 SMN1; SMN2 (0.50) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL17859666 0.81 SMN1; SMN2 (0.50) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL252121 0.78 TSHR (0.56) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL252883 0.78 TSHR (0.39) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL8060600 0.78 TSHR (0.56) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL175574 0.78 TSHR (0.39) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL1248748 0.77 SMN1; SMN2 (0.46) SMN1; SMN2TSHRMAPTKMT2AFAAH
SCHEMBL19729322 0.76 ALDH1A1 (0.53) SMN1; SMN2TSHRMAPTKMT2AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603858-A2 KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE NeuroSearch A/S (DK) 2005-12-14 EP disclosed
WO-2004080377-A2 KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE NEUROSEARCH A/S (DK) 2004-09-23 WO disclosed